Devonian Health Group Inc. DVHGF
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -90.68% | -67.34% | -25.85% | 18.62% | 207.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -90.68% | -67.34% | -25.85% | 18.62% | 207.93% |
| Cost of Revenue | -95.33% | -72.32% | -27.99% | 23.19% | 198.52% |
| Gross Profit | -82.50% | -57.99% | -22.17% | 11.38% | 225.99% |
| SG&A Expenses | -20.95% | -14.16% | -15.83% | 4.90% | 62.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 4.91% | 3.57% | 1.78% | 1.45% | 0.45% |
| Total Operating Expenses | -70.42% | -52.04% | -20.33% | 18.73% | 132.18% |
| Operating Income | -663.71% | -609.54% | -216.76% | -22.16% | 137.42% |
| Income Before Tax | -63.77% | -1,717.00% | -615.87% | -438.69% | -15.23% |
| Income Tax Expenses | -101.26% | -100.99% | -51.93% | -51.93% | 264.05% |
| Earnings from Continuing Operations | -28.80% | -1,100.60% | -289.18% | -214.08% | -34.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.80% | -1,100.60% | -289.18% | -214.08% | -34.74% |
| EBIT | -663.71% | -609.54% | -216.76% | -22.16% | 137.42% |
| EBITDA | -523.60% | -440.25% | -733.66% | -99.72% | 156.83% |
| EPS Basic | -15.88% | -1,040.37% | -275.65% | -209.06% | -33.41% |
| Normalized Basic EPS | -673.10% | -784.78% | -68.70% | 26.67% | 129.33% |
| EPS Diluted | -15.88% | -1,040.37% | -227.18% | -170.53% | -23.97% |
| Normalized Diluted EPS | -673.10% | -746.60% | -74.88% | 24.34% | 129.62% |
| Average Basic Shares Outstanding | 8.97% | 6.08% | 3.41% | 0.82% | 0.97% |
| Average Diluted Shares Outstanding | 8.97% | 3.67% | 1.06% | -1.49% | -1.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |